These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 25340261)
1. Development and characterization of arteether-loaded nanostructured lipid carriers for the treatment of malaria. Ali Z; Mishra N; Baldi A Artif Cells Nanomed Biotechnol; 2016; 44(2):545-9. PubMed ID: 25340261 [TBL] [Abstract][Full Text] [Related]
2. Sustained-release liquisolid compact tablets containing artemether-lumefantrine as alternate-day regimen for malaria treatment to improve patient compliance. Nnamani PO; Ugwu AA; Ibezim EC; Kenechukwu FC; Akpa PA; Ogbonna JN; Obitte NC; Odo AN; Windbergs M; Lehr CM; Attama AA Int J Nanomedicine; 2016; 11():6365-6378. PubMed ID: 27932882 [TBL] [Abstract][Full Text] [Related]
3. Development of artemether-loaded nanostructured lipid carrier (NLC) formulation for topical application. Nnamani PO; Hansen S; Windbergs M; Lehr CM Int J Pharm; 2014 Dec; 477(1-2):208-17. PubMed ID: 25290810 [TBL] [Abstract][Full Text] [Related]
4. An oral malaria therapy: curcumin-loaded lipid-based drug delivery systems combined with β-arteether. Memvanga PB; Coco R; Préat V J Control Release; 2013 Dec; 172(3):904-13. PubMed ID: 24021359 [TBL] [Abstract][Full Text] [Related]
5. In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers. Rashidzadeh H; Salimi M; Sadighian S; Rostamizadeh K; Ramazani A Curr Drug Deliv; 2019; 16(10):923-930. PubMed ID: 31663477 [TBL] [Abstract][Full Text] [Related]
6. Ameliorating the in vivo antimalarial efficacy of artemether using nanostructured lipid carriers. Vanka R; Kuppusamy G; Praveen Kumar S; Baruah UK; Karri VVSR; Pandey V; Babu PP J Microencapsul; 2018 Mar; 35(2):121-136. PubMed ID: 29448884 [TBL] [Abstract][Full Text] [Related]
7. Development of artemether and lumefantrine co-loaded nanostructured lipid carriers: physicochemical characterization and in vivo antimalarial activity. Parashar D; Aditya NP; Murthy RS Drug Deliv; 2016; 23(1):123-9. PubMed ID: 24786480 [TBL] [Abstract][Full Text] [Related]
8. Arthemeter-loaded lipid nanoparticles produced by modified thin-film hydration: Pharmacokinetics, toxicological and in vivo anti-malarial activity. Aditya NP; Patankar S; Madhusudhan B; Murthy RS; Souto EB Eur J Pharm Sci; 2010 Aug; 40(5):448-55. PubMed ID: 20493255 [TBL] [Abstract][Full Text] [Related]
9. Targeted Nanostructured Lipid Carrier for Brain Delivery of Artemisinin: Design, Preparation, Characterization, Optimization and Cell Toxicity. Emami J; Yousefian H; Sadeghi H J Pharm Pharm Sci; 2018; 21(1s):225s-241s. PubMed ID: 30266137 [TBL] [Abstract][Full Text] [Related]
14. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation. Khan S; Baboota S; Ali J; Narang RS; Narang JK Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780 [TBL] [Abstract][Full Text] [Related]
15. Teratogenicity of Artemether-Clindamycin Nanostructured Lipid Carriers in Rats. Jain SA; Awale M; Pathak S; Vanage G; Patravale VB; Sharma S Int J Toxicol; 2016 Jul; 35(4):420-8. PubMed ID: 27278417 [TBL] [Abstract][Full Text] [Related]
16. Development of SMEDDS using natural lipophile: application to beta-Artemether delivery. Mandawgade SD; Sharma S; Pathak S; Patravale VB Int J Pharm; 2008 Oct; 362(1-2):179-83. PubMed ID: 18652886 [TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory activity of injectable dexamethasone acetate-loaded nanostructured lipid carriers. Xu X; Zhao C; Yang H; Jian Y; Zhang Z; Huang Y Drug Deliv; 2011; 18(7):485-92. PubMed ID: 21692681 [TBL] [Abstract][Full Text] [Related]